首页> 美国卫生研究院文献>Oncotarget >Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas
【2h】

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas

机译:设计用于MDV-1的miRNA海绵作为抗淋巴瘤的治疗策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lymphomas are solid-type tumors containing lymphoid cells. Some of latent herpesvirus infections established in B and/or T-lymphocytes could result in the formation of lymphomas. Marek's disease virus serotype 1 (MDV-1) is an avian herpes virus causing to lymphoproliferative tumors in birds, known as Marek’s disease (MD). MD has often been used as an ideal biological model for studying the pathogenesis of lymphoma diseases caused by viruses. Therefore, we used it as a research subject to study the effect of miRNA sponges on its tumorigenicity, and to develop the theoretical basis for a new anti-tumor small molecule. The miRNA sponges designed in this study specifically bind to and degrade the miRNAs of meq gene cluster of MDV-1, including miR-M2-3p, miR-M3-5p, miR-M5-3p, miR-M9-5p and miR-M12-3p.qPCR results showed that the knockdown efficiency was 85.03%, 74.97%, 47.06%, 75.33% and 62.55%, respectively. EDU staining and CCK-8 results showed that miRNA sponges inhibited the proliferation of MDV-1 transformed MSB-1 cells in vitro, and the proliferation rate of miRNA sponges-treated cells was about 50% of the control group. DAPI staining and Annxin V-FITC/PI double staining showed that miRNA sponges induced apoptosis in MSB-1 cells, and the apoptotic rate was increased by about 27.87% compared with the control group. The results of transwell showed that miRNA sponges could inhibit the invasion of MSB-1 cells in vitro, and the inhibitory rate was about 64.52%. The soft agar assay showed that miRNA sponges could inhibit the tumorigenic ability of MSB-1 cells in vitro, and the inhibitory rate was about 66.44%.The 60-days animal study showed that miRNA sponges could alleviate the growth inhibition of MSB-1 cells (about 14.78%) and reduce the mortality (about 16.00%). In addition, the tumor formation rate was 0 (8–12% in the control group).This study suggests that miRNA sponges can serve as an effective anti-tumor small molecule for the tumors caused by herpesvirus, with potential clinical implications.
机译:淋巴瘤是含有淋巴样细胞的实体型肿瘤。在B和/或T淋巴细胞中建立的一些潜在的疱疹病毒感染可能导致淋巴瘤的形成。马立克氏病病毒血清型1(MDV-1)是一种禽疱疹病毒,可导致鸟类的淋巴增生性肿瘤,称为马立克氏病(MD)。 MD经常被用作研究病毒引起的淋巴瘤疾病的发病机理的理想生物学模型。因此,我们将其作为研究对象来研究miRNA海绵对其致瘤性的影响,并为新型抗肿瘤小分子的发展奠定理论基础。在这项研究中设计的miRNA海绵特异性结合并降解MDV-1的meq基因簇的miRNA,包括miR-M2-3p,miR-M3-5p,miR-M5-3p,miR-M9-5p和miR- M12-3p.qPCR结果显示,敲除效率分别为85.03%,74.97%,47.06%,75.33%和62.55%。 EDU染色和CCK-8结果表明,miRNA海绵在体外抑制MDV-1转化的MSB-1细胞的增殖,经miRNA海绵处理的细胞的增殖率为对照组的约50%。 DAPI染色和Annxin V-FITC / PI双重染色显示miRNA海绵诱导MSB-1细胞凋亡,与对照组相比,凋亡率提高了约27.87%。 Transwell结果表明,miRNA海绵在体外能抑制MSB-1细胞的侵袭,抑制率约为64.52%。软琼脂分析表明miRNA海绵可以抑制MSB-1细胞的体外致瘤能力,抑制率约为66.44%。60天的动物研究表明miRNA海绵可以减轻MSB-1细胞的生长抑制作用。 (约14.78%),并降低死亡率(约16.00%)。此外,肿瘤形成率为0(对照组为8–12%)。这项研究表明,miRNA海绵可以作为疱疹病毒引起的肿瘤的有效抗肿瘤小分子,具有潜在的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号